|
ZNF786 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.638800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.802800E-01 |
| Normal-vs-Stage2 |
2.409600E-01 |
| Normal-vs-Stage3 |
7.073200E-01 |
| Normal-vs-Stage4 |
6.048200E-01 |
| Stage1-vs-Stage2 |
5.125200E-01 |
| Stage1-vs-Stage3 |
5.690600E-01 |
| Stage1-vs-Stage4 |
1.465620E-01 |
| Stage2-vs-Stage3 |
3.232000E-01 |
| Stage2-vs-Stage4 |
1.156250E-01 |
| Stage3-vs-Stage4 |
3.696200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.601600E-01 |
| Normal-vs-AfricanAmerican |
6.135800E-01 |
| Normal-vs-Asian |
1.157520E-02 |
| Caucasian-vs-AfricanAmerican |
2.954200E-01 |
| Caucasian-vs-Asian |
2.501600E-02 |
| AfricanAmerican-vs-Asian |
1.364100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.336600E-01 |
| Normal-vs-Female |
3.737800E-01 |
| Male-vs-Female |
3.391600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.744400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.710000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.596000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.676200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.623600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.853200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.419400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.585800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.247000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.821000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.314100E-02 |
| Classical-VS-Follicular |
1.756040E-04 |
| Classical-VS-Other |
3.742000E-01 |
| Classical-VS-Normal |
6.697800E-02 |
| Tall-VS-Follicular |
6.822000E-01 |
| Tall-VS-Other |
8.354800E-01 |
| Tall-VS-Normal |
5.428600E-01 |
| Follicular-VS-Other |
7.274400E-01 |
| Follicular-VS-Normal |
2.913400E-01 |
| Other-VS-Normal |
8.923200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.023200E-01 |
| Normal-vs-N1 |
8.246800E-01 |
| N0-vs-N1 |
2.857000E-01 |
|
|
